947371-20-2Relevant articles and documents
Discovery of N-{(1S,2S)-2-(3-cyanophenyl)-3-[4-(2-[18F] fluoroethoxy)phenyl]-1-methylpropyl}-2-methyl-2-[(5-methylpyridin-2-yl)oxy] propanamide, a cannabinoid-1 receptor positron emission tomography tracer suitable for clinical use
Liu, Ping,Lin, Linus S.,Hamill, Terence G.,Jewell, James P.,Lanza Jr., Thomas J.,Gibson, Raymond E.,Krause, Stephen M.,Ryan, Christine,Eng, Waisi,Sanabria, Sandra,Tong, Xinchun,Wang, Junying,Levorse, Dorothy A.,Owens, Karen A.,Fong, Tung M.,Shen, Chun-Pyn,Lao, Julie,Kumar, Sanjeev,Yin, Wenji,Payack, Joseph F.,Springfield, Shawn A.,Hargreaves, Richard,Burns, H. Donald,Goulet, Mark T.,Hagmann, William K.
, p. 3427 - 3430 (2008/02/10)
The discovery of a structurally distinct cannabinoid-1 receptor (CB1R) positron emission tomography tracer is described. Starting from an acyclic amide CB1R inverse agonist (1) as the lead compound, an efficient route to introduce 18F to the mo